Clinical trial
CAPA In-vitro Oocyte Maturation
NCT07083427 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CAPA In-vitro Oocyte Maturation
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2025
- Completion date
- July 1, 2036
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.